Home Cart 0 Sign in  

[ CAS No. 1352132-34-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1352132-34-3
Chemical Structure| 1352132-34-3
Structure of 1352132-34-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1352132-34-3 ]

Related Doc. of [ 1352132-34-3 ]

Alternatived Products of [ 1352132-34-3 ]

Product Details of [ 1352132-34-3 ]

CAS No. :1352132-34-3 MDL No. :MFCD18731015
Formula : C14H19BO3 Boiling Point : -
Linear Structure Formula :- InChI Key :GQYGIWURVFRSCU-UHFFFAOYSA-N
M.W : 246.11 Pubchem ID :127263688
Synonyms :

Calculated chemistry of [ 1352132-34-3 ]

Physicochemical Properties

Num. heavy atoms : 18
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.5
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 73.27
TPSA : 35.53 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.86 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 2.74
Log Po/w (WLOGP) : 2.11
Log Po/w (MLOGP) : 1.31
Log Po/w (SILICOS-IT) : 2.52
Consensus Log Po/w : 1.74

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.21
Solubility : 0.153 mg/ml ; 0.000621 mol/l
Class : Soluble
Log S (Ali) : -3.14
Solubility : 0.178 mg/ml ; 0.000723 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.34
Solubility : 0.0113 mg/ml ; 0.0000459 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 2.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.91

Safety of [ 1352132-34-3 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P405-P305+P351+P338-P304+P340-P280 UN#:
Hazard Statements:H335-H315-H319 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1352132-34-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 1352132-34-3 ]

[ 1352132-34-3 ] Synthesis Path-Downstream   1~8

  • 1
  • [ 76-09-5 ]
  • [ 1106869-99-1 ]
  • [ 1352132-34-3 ]
YieldReaction ConditionsOperation in experiment
With magnesium sulfate In methanol at 20℃; for 6h; General procedure: To a mixture of a4-formylbenzenboronic acid (1a, 375 mg, 2.50 mmol), pinacol (355 mg, 3.00 mmol) and anhydrous magnesium sulfate (625 mg, 5.00 mmol), methanol was added (12.50 mL). The mixture was stirred at room temperature for 6 h. After the reaction was completed, the crude solution was filtered, and then sodium borohydride (47 mg, 1.25 mmol) was added to the filtrate. Afterwards, the reaction mixture was stirred for an additional 5 h. Once the reaction was completed, the reaction mixture was filtered and the filtrate was concentrated in vacuo to give the desired product 2a as a white solid (m.p. 75-77 °C) in88% yield (513 mg). 1H-NMR (CD3OD-d4) δ ppm 7.71 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 7.8 Hz, 2H),4.62 (s, 2H), 1.34 (s, 12H); 13C-NMR (CD3OD-d4) δ ppm 146.23, 135.93, 127.26, 85.19, 65.24, 25.34;11B-NMR (CDCl3) δ ppm 34.82.
  • 2
  • [ 1352132-34-3 ]
  • [ 1544673-61-1 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1: sodium tetrahydroborate / 5 h / 20 °C 2: N-ethyl-N,N-diisopropylamine / dichloromethane / 3 h / 0 °C / Inert atmosphere 3: potassium carbonate / N,N-dimethyl-formamide / 72 h / 20 °C
  • 3
  • [ 1352132-34-3 ]
  • [ 1544673-80-4 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1: sodium tetrahydroborate / 5 h / 20 °C 2: N-ethyl-N,N-diisopropylamine / dichloromethane / 3 h / 0 °C / Inert atmosphere 3: potassium carbonate / N,N-dimethyl-formamide / 72 h / 20 °C 4: hydrazine hydrate / tetrahydrofuran / 12 h / Reflux
  • 4
  • [ 1352132-34-3 ]
  • C15H23BO5S [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: sodium tetrahydroborate / 5 h / 20 °C 2: N-ethyl-N,N-diisopropylamine / dichloromethane / 3 h / 0 °C / Inert atmosphere
  • 5
  • [ 1352132-34-3 ]
  • [ 1544673-46-2 ]
YieldReaction ConditionsOperation in experiment
312 mg With sodium tetrahydroborate at 20℃; for 5h; [4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanol (2a). General procedure: To a mixture of a4-formylbenzenboronic acid (1a, 375 mg, 2.50 mmol), pinacol (355 mg, 3.00 mmol) and anhydrous magnesium sulfate (625 mg, 5.00 mmol), methanol was added (12.50 mL). The mixture was stirred at room temperature for 6 h. After the reaction was completed, the crude solution was filtered, and then sodium borohydride (47 mg, 1.25 mmol) was added to the filtrate. Afterwards, the reaction mixture was stirred for an additional 5 h. Once the reaction was completed, the reaction mixture was filtered and the filtrate was concentrated in vacuo to give the desired product 2a as a white solid (m.p. 75-77 °C) in88% yield (513 mg). 1H-NMR (CD3OD-d4) δ ppm 7.71 (d, J = 8.0 Hz, 2H), 7.35 (d, J = 7.8 Hz, 2H),4.62 (s, 2H), 1.34 (s, 12H); 13C-NMR (CD3OD-d4) δ ppm 146.23, 135.93, 127.26, 85.19, 65.24, 25.34;11B-NMR (CDCl3) δ ppm 34.82.
  • 6
  • [ 18100-53-3 ]
  • [ 73183-34-3 ]
  • [ 25015-63-8 ]
  • [ 1352132-34-3 ]
YieldReaction ConditionsOperation in experiment
71% With (1,5-cyclooctadiene)(methoxy)iridium(I) dimer; 3,4,7,8-Tetramethyl-o-phenanthrolin In tetrahydrofuran at 90℃; for 12h; Glovebox;
  • 7
  • [ 55276-43-2 ]
  • [ 1352132-34-3 ]
  • 1-(2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)-4-(methylsulfonyl)piperazine [ No CAS ]
YieldReaction ConditionsOperation in experiment
A solution of 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde (100 mg, 0.4 mmol), 1-(methylsulfonyl)piperazine (0.080 g, 0.49 mmol), and acetic acid (50 muL, 0.9 mmol) in methylene chloride (6 mL) was first stirred for 30 minutes, then sodium triacetoxyborohydride (260 mg, 1.2 mmol) was added and the reaction mixture was stirred at room temperature overnight. The mixture was diluted with methylene chloride, was with saturated NaHCO3, water, and brine, dried over sodium sulfate, and concentrated. The residue was used in the next step without further purification. LC-MS calculated for C19H32BN2O4S (M+H)+: m/z=395.2. found 395.2.
  • 8
  • [ 90050-59-2 ]
  • [ 73183-34-3 ]
  • [ 1352132-34-3 ]
YieldReaction ConditionsOperation in experiment
54% With potassium acetate; palladium diacetate; In N,N-dimethyl-formamide; at 85℃; for 3h;Inert atmosphere; Sealed tube; A stream of nitrogen gas was bubbled through a mixture of <strong>[90050-59-2]5-bromo-2-methylbenzaldehyde</strong> (1550 mg, 7.79 mmol), 4,4,5,5,4',4',5',5'-octamethyl-[2,2']bi[[1,3,2]dioxaborolanyl](2200 mg, 8.6 mmol), and potassium acetate (2300 mg, 23 mmol) in N,N-dimethylformamide (30 mL) for ?15 minutes. Then palladium acetate (90 mg, 0.4 mmol) was added, the vial was sealed, and the reaction was heated to 85 C. for 3 h. After cooling, the mixture was concentrated and the residue was partitioned between 75 mL of EtOAc and 75 mL water. The suspension was filtered through celite, the filter cake was washed with EtOAc, then the layers were separated. The organic phase was washed with water, brine, dried over sodium sulfate, and concentrated. The residue was purified by flash chromatography on a silica gel column eluting with 0 to 10% EtOAc/hexanes to give the desired compound (1025 mg, 54%). LC-MS calculated for C14H20BO3 (M+H)+: m/z=247.2. found 247.1.
Same Skeleton Products
Historical Records